Sam Brusco, Associate Editor07.03.23
U.S. Medical Innovations (USMI), the biomedical and life science subsidiary of U.S. Patent Innovations, has earned U.S. Food and Drug Administration (FDA) approval for its Canady Flex RoboWrist robotic surgery device for open and laparoscopic surgeries.
Flex RoboWrist—already approved in the Middle East, Europe, and Asia—is a fully articulating motorized, 5 mm handheld surgical instrument with a range of end effectors including a hook, sciessors, needle driver, and dissector offering 3 degrees of freedom and 360 degrees of rotation. It has a connector for the USMI XL-1000 electrosurgical generator, giving the option of using the mono scissors or hook for electrosurgery.
Flex RoboWrist is mainly intended for tissue dissection, transection, and/or suturing during open, endoscopic, and minimally invasive procedures like laparoscopic, urologic, gynecologic, general, and thoracic surgeries.
Jerome Canady, MD, FACS and CEO of US Medical Innovations, LLC, told the press, "The Flex RoboWrist represents a significant advancement in laparoscopic surgical technology and will empower surgeons to achieve exceptional results and redefine the possibilities of laparoscopic surgical procedures. The flexible design provides motorized control of two movements that are essential to accessing surgical sites and laparoscopic suturing: bidirectional deflection and unlimited rotation of the distal jaws of the instrument.”
The robotic tech promotes precise movements to reduce risk of human error and boost surgical outcomes. Flex RoboWrist has automation and intelligent control systems to optimize surgical workflows and save OR time. It’s also autoclavable up to 50 times and doesn’t need disposables.
Flex RoboWrist—already approved in the Middle East, Europe, and Asia—is a fully articulating motorized, 5 mm handheld surgical instrument with a range of end effectors including a hook, sciessors, needle driver, and dissector offering 3 degrees of freedom and 360 degrees of rotation. It has a connector for the USMI XL-1000 electrosurgical generator, giving the option of using the mono scissors or hook for electrosurgery.
Flex RoboWrist is mainly intended for tissue dissection, transection, and/or suturing during open, endoscopic, and minimally invasive procedures like laparoscopic, urologic, gynecologic, general, and thoracic surgeries.
Jerome Canady, MD, FACS and CEO of US Medical Innovations, LLC, told the press, "The Flex RoboWrist represents a significant advancement in laparoscopic surgical technology and will empower surgeons to achieve exceptional results and redefine the possibilities of laparoscopic surgical procedures. The flexible design provides motorized control of two movements that are essential to accessing surgical sites and laparoscopic suturing: bidirectional deflection and unlimited rotation of the distal jaws of the instrument.”
The robotic tech promotes precise movements to reduce risk of human error and boost surgical outcomes. Flex RoboWrist has automation and intelligent control systems to optimize surgical workflows and save OR time. It’s also autoclavable up to 50 times and doesn’t need disposables.